Presentation Information
[3CTBP-03]Strategy for the Industrialization of MSC-based Private-pay Care: Establishing Superiority of Autologous Cells through Standardized Manufacturing
○Keita Inoue1 (1. CPC Corporation (Japan))
Keywords:
mesenchymal stem cells,cell therapy
Comment
To browse or post comments, you must log in.Log in
